Clinical Trial

INDUCE: A Prospective 2-Year Spine Registry

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The primary objective of this prospective, observational registry study is to evaluate the safety and effectiveness of Natural Matrix Protein® (NMP®) when used to promote fusion in the cervical or lumbar spine. The secondary objective is to assess patient reported outcomes following the use of NMP in the treatment of the spine.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-07; most recent amendment 2026-04-17.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-04-17
Trial Details
NCT Number NCT06971835
Lead Sponsor Red Rock Regeneration Inc.
Conditions Subjects Treated With NMP as Part of Their Spine Surgery, Degenerative Disc Disease (DDD)
Enrollment 1,000 participants
Start Date 2026-02-17
Primary Completion 2028-12 (estimated)
Study Completion 2029-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-22